Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Windtree Therapeutics Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 27 | 1 | 9 | −17 |
| Shares | 1.64M | 18.0K | 2.57K | −1.62M (−99.8%) |
| Value | $276.6K | $3.06K | $12.8K | −$260.7K (−95.3%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Windtree Therapeutics Inc at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (17)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Renaissance Technologies LLC | 335,700 | $57.0K |
| Envestnet Asset Management Inc | 212,236 | $36.1K |
| PVG Asset Management Corp | 187,060 | $31.8K |
| Vanguard Group Inc | 168,233 | $28.6K |
| Geode Capital Management, LLC | 158,747 | $26.0K |
| Skandinaviska Enskilda Banken AB (publ) | 110,500 | $19.0K |
| Millennium Management LLC | 84,420 | $14.0K |
| Northern Trust Corp | 50,176 | $8.53K |
| Rockwood Wealth Management, LLC | 35,101 | $5.97K |
| Cetera Investment Advisers | 29,795 | $5.07K |
| HRT Financial LP | 32,999 | $5.00K |
| Warberg Asset Management LLC | 25,000 | $4.26K |
| Virtu Financial LLC | 24,693 | $4.00K |
| State Street Corp | 20,270 | $3.45K |
| Two Sigma Securities, LLC | 18,949 | $3.22K |
| Cetera Advisors LLC | 10,299 | $1.75K |
| Banque Cantonale Vaudoise | 1 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Game Plan Financial Advisors, LLC | 18,000 | $3.06K |